Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) have received a consensus recommendation of “Hold” from the nine analysts that are currently covering the firm, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12 month price objective among analysts that have covered the stock in the last year is $56.57.
A number of equities research analysts recently commented on the stock. DA Davidson increased their price objective on shares of Nu Skin Enterprises from $61.00 to $68.00 and gave the company a “buy” rating in a research note on Friday, October 2nd. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Nu Skin Enterprises from $49.00 to $57.00 and gave the company a “hold” rating in a research note on Thursday, November 5th. Bank of America raised shares of Nu Skin Enterprises from an “underperform” rating to a “neutral” rating and increased their price objective for the company from $54.00 to $58.00 in a research note on Friday, October 2nd. Jefferies Financial Group increased their price objective on shares of Nu Skin Enterprises from $57.00 to $60.00 and gave the company a “buy” rating in a research note on Wednesday, September 30th. Finally, Zacks Investment Research lowered shares of Nu Skin Enterprises from a “strong-buy” rating to a “hold” rating and set a $57.00 target price on the stock. in a report on Wednesday, October 7th.
NUS traded down $1.82 during trading on Wednesday, hitting $56.26. The stock had a trading volume of 290,454 shares, compared to its average volume of 371,997. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.08 and a current ratio of 1.66. Nu Skin Enterprises has a twelve month low of $12.31 and a twelve month high of $59.71. The firm has a market capitalization of $2.87 billion, a P/E ratio of 19.56, a PEG ratio of 2.03 and a beta of 1.37. The company’s 50-day moving average price is $54.72 and its 200 day moving average price is $51.13.
In other Nu Skin Enterprises news, CFO Mark H. Lawrence sold 3,993 shares of the stock in a transaction that occurred on Tuesday, December 1st. The shares were sold at an average price of $50.61, for a total value of $202,085.73. Following the completion of the sale, the chief financial officer now owns 48,526 shares of the company’s stock, valued at $2,455,900.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, President Ryan S. Napierski sold 10,156 shares of the stock in a transaction that occurred on Wednesday, January 20th. The shares were sold at an average price of $59.12, for a total transaction of $600,422.72. Following the completion of the sale, the president now directly owns 83,656 shares of the company’s stock, valued at approximately $4,945,742.72. The disclosure for this sale can be found here. Insiders sold 58,593 shares of company stock worth $3,170,631 in the last 90 days. 3.40% of the stock is currently owned by insiders.
A number of institutional investors and hedge funds have recently made changes to their positions in NUS. AJO LP bought a new position in Nu Skin Enterprises during the third quarter worth $31,957,000. Nuveen Asset Management LLC lifted its stake in Nu Skin Enterprises by 317.9% during the second quarter. Nuveen Asset Management LLC now owns 453,781 shares of the company’s stock worth $17,348,000 after purchasing an additional 345,187 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Nu Skin Enterprises by 40.9% during the second quarter. Charles Schwab Investment Management Inc. now owns 741,271 shares of the company’s stock worth $28,339,000 after purchasing an additional 215,271 shares during the last quarter. LSV Asset Management bought a new stake in Nu Skin Enterprises in the third quarter valued at $5,915,000. Finally, JPMorgan Chase & Co. lifted its stake in Nu Skin Enterprises by 104.9% in the third quarter. JPMorgan Chase & Co. now owns 186,698 shares of the company’s stock valued at $9,130,000 after buying an additional 95,564 shares during the last quarter. Hedge funds and other institutional investors own 73.75% of the company’s stock.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products.
Read More: How Do Mutual Funds Work?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.